A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Fountzilas G, Athanassiades A, Giannakakis T, Briasoulis E, Bafaloukos D, Kalogera-Fountzila A, Onienaoum A, Kalofonos H, Pectasides D, Andreopoulou E, Bamia C, Kosmidis P, Pavlidis N, Skarlos D.
Fountzilas G, et al. Among authors: bafaloukos d.
Ann Oncol. 1997 Dec;8(12):1213-20. doi: 10.1023/a:1008270307264.
Ann Oncol. 1997.
PMID: 9496386
Free article.
Clinical Trial.